Order Article Reprints

Johansen AZ, Carretta M, Thorseth M-L, Khan S, Fjæstad KY, Brøchner CB, Linder H, Ankjærgaard C, Donia M, Chen I, et al. Chitooligosaccharides Improve the Efficacy of Checkpoint Inhibitors in a Mouse Model of Lung Cancer. Pharmaceutics. 2022; 14(5):1046. https://doi.org/10.3390/pharmaceutics14051046

Johansen, Astrid Zedlitz, Marco Carretta, Marie-Louise Thorseth, Shawez Khan, Klaire Yixin Fjæstad, Christian Beltoft Brøchner, Hannes Linder, Christina Ankjærgaard, Marco Donia, Inna Chen, and et al. 2022. "Chitooligosaccharides Improve the Efficacy of Checkpoint Inhibitors in a Mouse Model of Lung Cancer" Pharmaceutics 14, no. 5: 1046. https://doi.org/10.3390/pharmaceutics14051046

Johansen, A. Z., Carretta, M., Thorseth, M.-L., Khan, S., Fjæstad, K. Y., Brøchner, C. B., Linder, H., Ankjærgaard, C., Donia, M., Chen, I., Nielsen, D. L., Behrens, C. P., & Madsen, D. H. (2022). Chitooligosaccharides Improve the Efficacy of Checkpoint Inhibitors in a Mouse Model of Lung Cancer. Pharmaceutics, 14(5), 1046. https://doi.org/10.3390/pharmaceutics14051046